Henry Schein double upgraded to Buy from Underperform at BofA
BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...
Strategic Investment and Growth Potential Drive Buy Rating for Henry Schein Despite Underwhelming Guidance
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from ...
Henry Schein Inc. stock underperforms Tuesday when compared to competitors
This was the stock's fourth consecutive day of losses.
Newsday14d
Henry Schein gets $250 million investment from private equity firm KKR
Henry Schein and KKR said in its joint statement Wednesday the investment will give the company "expertise across finance, operations, and in dental and other areas of health care." The company ...
What Analysts Are Saying About Henry Schein Stock
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...
Morningstar8d
Velir Reimagines Henry Schein One's Digital Experience with Cutting-Edge Optimizely Implementation
This belief drove our collaboration with Henry Schein One, a division of Henry Schein, a leader in dental software solutions, to launch a dynamic new website designed to set the standard for ...
KKR builds stake in Henry Schein, reaches deal to add board seats
Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...
PE Hub14d
KKR invests in dental and medical supplies distributor Henry Schein
KKR has made an investment in Henry Schein Inc, a Melville, New York-based provider of healthcare solutions to office-based dental and medical practitioners. Stanley Bergman serves as CEO of Henry ...